Reference : Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Urology & nephrology
http://hdl.handle.net/2268/18135
Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire
English
Tancredi, Annalisa [Université de Liège - ULg > Département des sciences de la santé publique > Ecole de santé publique >]
Legros, Jean-Jacques mailto [Université de Liège - ULg > Département des sciences cliniques > Département des sciences cliniques >]
Pire, G. [> > > >]
Maassen, P. [> > > >]
Luyckx, Françoise mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chimie médicale >]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Epidémiologie et santé publique >]
Sep-2007
Aging Male : The Official Journal of the International Society for the Study of the Aging Male
Informa Healthcare-Taylor & Francis
10
3
159-164
Yes (verified by ORBi)
International
1368-5538
Abingdon
[en] ADAM ; andropause ; hypogonadism ; testosterone ; aging male
[en] Objective. To investigate whether shorter versions of the ADAM test, a screening questionnaire for andropause, provide better diagnostic value than the original tool. Methods. Five thousand and twenty-eight volunteer men aged 50-70 years attending a screening campaign for andropause, provided a fasting blood sample and completed the French ADAM test. Logistic regression analysis identified items that best predict andropause defined as serum free testosterone level below 70 ng/l. ROC curves assessed the diagnostic value of modified versions of the ADAM test, obtained by elimination of the less relevant predictors of andropause. Results. Only four items of the ADAM questionnaire may account for the diagnosis of andropause. These items concerned loss of height, decrease in libido and in enjoyment of life and deterioration in work performance. Item 9 was borderline significant. The area under the ROC curve for the short versions varied slightly from 0.555 to 0.560. As expected, model 6 has a greater specificity (56.02%) than the original tool while the efficiency increased slightly (54.85%). Conclusion. The modified versions of the ADAM test do not provide better diagnostic value than the original tool. Conclusion. The modified versions of the ADAM test do not provide better diagnostic value than the original tool.
http://hdl.handle.net/2268/18135
10.1080/13685530701433121

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
AgingMale.pdfPublisher postprint297.72 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.